osteoporosis

|health|medicinal chemistry|organic chemistry|analytical chemistry The future is very promising for the scientists the Merck Frosst’s Centre for therapeutic research.

Thanks to our work on asthma and arthritis shown by our discovery of SINGULAR® (montelukast sodium) and of VIOXX® (rofecoxib), we have become the world leaders in the understanding of the inflammatory process, and especially in the chemistry and biology of leukotriene and prostaglandins.







osteoporosis |
health | phd | molecular biology | cell biology | bioinformatic | medicinal chemistry | analytical chemistry | process chemistry | drug metabolism | Singular asthma | Arthritis Osteoporosis | Obesity Enzymes | Obesity Research | Molecular Diabetes | Diabetes Arthritis | spectroscopy | Pharmaceutical | computational chemistry | organic chemistry | proteomic | biotechnology | pharmacology | biochemistry | graduate | research | osteoporosis | diabetes | asthma | obesity | arthritis |